Literature DB >> 6088141

Chemotactic factor-induced enhancement of the binding of human immunoglobulin classes and subclasses to neutrophils and eosinophils.

A B Kay, G M Walsh.   

Abstract

Sheep erythrocytes (E) coated with either human IgG1, IgG2, IgG3 or IgG4 myeloma proteins formed rosettes with human neutrophils and eosinophils. Prior incubation with the chemotactic agents f-met-leu-phe or leukotriene B4 enhanced neutrophil and eosinophil E-IgG1 rosettes in a time- and dose-dependent fashion. There were comparable increases in neutrophil and eosinophil f-met-leu-phe-induced rosettes with either E-IgG1, E-IgG2, E-IgG3 or E-IgG4 whereas this agent did not appear to influence E-IgA1, E-IgD, E-IgM or E-IgE binding to these granulocytes. These studies indicate that human neutrophil and eosinophil IgG (Fc) receptors are enhanced by chemotactic agents in a similar way to that previously described for complement receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088141      PMCID: PMC1536276     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors.

Authors:  A R Anwar; A B Kay
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

2.  Membrane receptors for IgG and complement (C4, C3b and C3d) on human eosinophils and neutrophils and their relation to eosinophilia.

Authors:  A R Anwar; A B Kay
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Leucoattractants enhance complement receptors on human phagocytic cells.

Authors:  A B Kay; E J Glass; D M Salter
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

4.  Leukocyte chemotactic factors and the C3b receptor.

Authors:  A B Kay; A J Duncan; E J Glass; J Stewart
Journal:  Kroc Found Ser       Date:  1981

5.  Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides.

Authors:  A R Anwar; J R McKean; S R Smithers; A B Kay
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

6.  A subpopulation of normal human peripheral B lymphcytes that bind IgE.

Authors:  A Gonzalez-Molina; H L Spiegelberg
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

7.  Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor.

Authors:  M Capron; A Capron; E J Goetzl; K F Austen
Journal:  Nature       Date:  1981-01-01       Impact factor: 49.962

8.  Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products.

Authors:  L Nagy; T H Lee; E J Goetzl; W C Pickett; A B Kay
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

9.  Complement receptor enhancement as evidence of neutrophil activation after exercise-induced asthma.

Authors:  N Papageorgiou; M Carroll; S R Durham; T H Lee; G M Walsh; A B Kay
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

10.  Role of IgE receptors in effector function of human eosinophils.

Authors:  M Capron; H L Spiegelberg; L Prin; H Bennich; A E Butterworth; R J Pierce; M A Ouaissi; A Capron
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

View more
  8 in total

Review 1.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

Review 2.  Eosinophils. Assays and interpretation.

Authors:  D E Maddox
Journal:  Clin Rev Allergy       Date:  1988

3.  The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils.

Authors:  P Fitzharris; R Moqbel; K J Thorne; B A Richardson; A Hartnell; O Cromwell; A E Butterworth; A B Kay
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

Review 4.  Eosinophils as effector cells in immunity and hypersensitivity disorders.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

5.  Characterization of the IgA receptor from human polymorphonuclear leucocytes.

Authors:  M Albrechtsen; G R Yeaman; M A Kerr
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

6.  Leukotriene B4 generation by human neutrophils following IgG-dependent stimulation.

Authors:  P Fitzharris; O Cromwell; R Moqbel; A Hartnell; G M Walsh; C Harvey; A B Kay
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

7.  The effect of platelet-activating factor on IgE binding to, and IgE-dependent biological properties of, human eosinophils.

Authors:  R Moqbel; G M Walsh; T Nagakura; A J MacDonald; A J Wardlaw; Y Iikura; A B Kay
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

8.  Enhancement of human neutrophil complement receptors: a comparison of the rosette technique with the uptake of radio-labelled anti-CR1 monoclonal antibody.

Authors:  H B Richerson; G M Walsh; M J Walport; R Moqbel; A B Kay
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.